Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1915835Generated: November 1, 2026

1-Methyl-1,4-cyclohexadiene → HCID 86680046, compound

https://huagongshe.com/reaction/1915835

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1-Methyl-1,4-cyclohexadieneHCID 78006—
ReactantPotassium FluorideHCID 522689—
Reactant5-chloro-1-methyl-4-nitro-1H-pyrazoleHCID 12344836—
ReactantHCID 86680047HCID 86680047—
CatalystPalladiumHCID 23938—
SolventDimethyl SulfoxideHCID 679—
SolventEthanolHCID 702—
ProductHCID 86680046HCID 86680046—

Reaction Conditions

Temperature60 °C

Reaction Steps

To a solution of benzyl 3a-methyl-2-oxo-3,4,5,7,8,8a-hexahydrooxazolo[4,5-d]azepine-6-carboxylate (305 mg, 1.0 mmol) and 1-methyl-1,4-cyclohexadiene (1.1 mL, 10.00 mmol) in EtOH (10 mL) was added 10% palladium on carbon (53 mg, 0.50 mmol) under nitrogen and the mixture was heated at 60° C. for 2 hr. The mixture was cooled to room temperature, filtered through Celite® and concentrated under reduced pressure. To a solution of the residue (170 mg, 1.00 mmol) in DMSO (5 mL) was added 5-chloro-1-methyl-4-nitro-pyrazole (178 mg, 1.10 mmol) and potassium fluoride (232 mg, 4.00 mmol) and the mixture was heated in the microwave at 110° C. for 4 hr. The reaction was quenched with water (20 mL) and extracted with EtOAc (3×5 mL). The combined organic layers were passed through a phase separation cartridge and concentrated under reduced pressure. Purification via silica gel chromatography (0-5% MeOH/DCM) gave a yellow solid (220 mg, 74% over two steps). The material was combined with another batch to give 350 mg for separation of the diastereoisomers by reverse-phase preparative HPLC. The major diastereomer was isolated as a yellow solid (196 mg, 67% over two steps) 1H NMR (400 MHz, d6-DMSO) δ 8.11 (s, 1H), 7.72 (s, 1H), 4.48 (dd, J=6.6, 2.7 Hz, 1H), 3.74 (s, 3H), 3.10-3.01 (m, 2H), 2.20-1.96 (m, 3H), 1.85 (dd, J=15.2, 7.8 Hz, 1H), 1.32 (s, 3H). Two protons under water peak. LCMS (ES+) m/z 296 (M+1).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08614206B2
Source datasetuspto-grants-2013_12
ORD IDord-c562f25bee8c4cdc9501666040422ffd
Source noteuspto-grants-2013_12